Note From Brett: Everyone is talking about AI these days... but Doc Eifrig says most investors are missing the biggest story in artificial intelligence. And his phenomenal track record gives credence to his latest announcement. You can watch his message in full for free here, or see the email below from our publisher, Brett Aitken...
Dear Reader, I've said this before but it's worth repeating... Dr. David Eifrig's results are world-class. He has the best stock-picking track record over a decade or more at Stansberry Research... He's received an "A" more times on our track record report cards than anyone else... His Retirement Trader research is sitting on a 94% all-time win rate – over more than 14 years... He's shown Retirement Millionaire readers gains as high as 1,390%... with a 90% win rate and an average gain of 131% on open positions... But if you don't act soon, you will miss out on his new research where he suspects the highest gains he'll ever recommend will be. Keep in mind: Doc's done all this without taking big risks – ever – or getting involved in investing "fads" that usually end in disaster. And now, after 17 years at Stansberry Research – and more than four decades in the markets as an investing pro – he's sharing the most important (and highest potential upside) research of his life. The culmination of everything he's ever done – inside and outside of finance. And the work he says will remain his legacy decades from now. If you haven't seen Doc's huge announcement yet (plus your special invitation) – see it right here. I guarantee it will be worth your time, even if you never spend a penny on new research. It's heartfelt... personal... and absolutely fascinating. And what Doc reveals will definitely affect your health and well-being (as well as your wealth) for years to come. I'd argue you already see signs of what he's discussing all around you... But Doc will show you how to connect the dots. More important, the opportunity Doc is sharing could: - And show you gains as high as 300% in the coming years in a handful of emerging technology stocks driving the complete transformation of health care.
That combination of upside and low risk is simply extraordinary in this roller-coaster market. And just one more thing you might not have heard about yet... Because I really don't want you to miss this: One of Doc's recommendations pays a nearly 9% dividend yield today. Meaning it essentially wipes out all the effects of inflation just for owning it. And that's before the potential capital upside... in a business that millions of Americans will have pretty much no choice but to use in the coming years. (See why, right here.) I've known Doc for more than a decade... He's always had a steady hand through every market crisis. And he's one of the top-performing analysts at our company. But he's never been big on making predictions. He's too humble (and too smart) to get involved in trying to guess what a bunch of economists at a Fed meeting are going to do next... or anything like that. But this is something altogether different. Doc doesn't hold anything back in this presentation. And why should he? He's speaking from nearly half a century of expertise. This is his wheelhouse. His life's work. He says that knowing about this story could add years to your life – or even save it. (It could also save you hundreds of thousands – or more – in medical costs.) When he says this is the AI story no one is telling... and that most investors are simply missing the biggest artificial intelligence opportunity – believe him. When he says he expects his "Fortress Stocks" to go up year after year, no matter what happens in the economy – I know I wouldn't bet against him. You'll always be welcome, of course, to join this research at any time in the future – if you don't mind paying full price. But this is a limited-time special invitation. Doc's including four research reports... an exclusive video presentation... one of his most popular books... and a lot more. But all of that ends very soon... and this offer will not be repeated. Please access it right here today. Regards, Brett Aitken Publisher, Stansberry Research |